Martina Weise

Company: BfArM, Federal Institute for Drugs and Medical Devices

Martina Weise, MD, works at the Federal Institute for Drugs and Medical Devices (BfArM), Germany, since 2001, where she is currently Head of the Unit on Diabetes/Cardiovascular System. She is also the alternate German member of the European Committee for Medicinal products for Human Use (CHMP) and Vice Chair of the Biosimilar Medicinal Working Party (BMWP). She has extensive experience in drafting biosimilarity guidelines for the EMA and the WHO and, with her team, reviews biosimilar applications in the EU.

Dr. Weise is board-certified pediatrician, has over 10 years of professional experience in pediatrics including pediatric endocrinology and clinical and laboratory research in Germany and the USA. She has also published various scientific articles in international peer-reviewed journals focused on growth and adrenal disorders and, more recently, on biosimilars.